Tumor-associated macrophages (TAMs) play a central role in tumor progression, metastasis, and recurrence after treatment. Macrophage plasticity and diversity allow their classification …
AK Deshantri, AV Moreira, V Ecker… - Journal of Controlled …, 2018 - Elsevier
Hematological malignancies (HM) are a collection of malignant transformations originating from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …
To identify new therapeutic targets in acute myeloid leukemia (AML), we performed small- molecule and small-interfering RNA (siRNA) screens of primary AML patient samples. In …
UE Höpken, A Rehm - Trends in cancer, 2019 - cell.com
Despite progress in exploiting therapeutically the genetic vulnerabilities of leukemia and lymphoma, the outcome is often extended progression-free survival but not tumor …
C Martines, S Chakraborty, M Vujovikj… - Blood, The Journal …, 2022 - ashpublications.org
A large amount of circumstantial evidence has accumulated suggesting that Toll-like receptor (TLR) signals are involved in driving chronic lymphocytic leukemia (CLL) cell …
E Cencini, A Fabbri, A Sicuranza, A Gozzetti… - Cancers, 2021 - mdpi.com
Simple Summary Tumor-associated macrophages (TAM) represent a leading component of the tumor microenvironment in hematologic malignancies. TAM could display antitumor …
Y Man, X Yao, T Yang, Y Wang - Frontiers in Cell and Developmental …, 2021 - frontiersin.org
Self-renewal and multidirectional differentiation of hematopoietic stem cells (HSCs) are strictly regulated by numerous cellular components and cytokines in the bone marrow (BM) …
JG Valero, A Matas-Céspedes, F Arenas, V Rodriguez… - Leukemia, 2021 - nature.com
Microenvironment contributes to follicular lymphoma (FL) pathogenesis and impacts survival with macrophages playing a controversial role. In the present study, using FL primary …
SE Kurtz, CA Eide, A Kaempf… - Proceedings of the …, 2017 - National Acad Sciences
Translating the genetic and epigenetic heterogeneity underlying human cancers into therapeutic strategies is an ongoing challenge. Large-scale sequencing efforts have …